GPR40 activation via GW9508 restores thymic epithelial cell function in aged mice by suppressing senescence pathways and restoring T-cell production. This addresses immunosenescence—a primary driver of age-related vulnerability to infection, malignancy, and autoimmune dysfunction.
Key Points
- GPR40 expression declines in aged thymic epithelial cells and senescent states
- GW9508 activation restores calcium signaling and suppresses ERK1/2-MAPK hyperactivation
- Restored thymic function enhanced T-cell production in aged mice
Longevity Analysis
The thymus orchestrates adaptive immune competence throughout life; its age-related degeneration (involution) is a measurable hallmark of immunosenescence and a quantifiable predictor of mortality risk. GPR40-targeted interventions demonstrate that senescence in thymic epithelial cells is not merely a passive consequence of aging but a reversible state—one amenable to pharmacological intervention. The mechanism involves restoration of calcium handling and suppression of maladaptive stress signaling, both core cellular processes that deteriorate with age. Success in animal models suggests that targeting GPR40 could selectively enhance the body's capacity to generate new T cells, directly counteracting the immune weakness that underlies late-life infection risk, cancer incidence, and autoimmune disease prevalence.
Original published by Wiley Aging Cell, by Qingqing Li, Ping Zhu, Lihong Cui, Fenghua Luo, Yongqin Zhou, Yuanyuan Hu, Chunyan Luo, Shanshan Han, Xie Ding, Maoxi Yao, Honggang Yuan, Yinhong Song .